Medicover AB (LTS:0RPS) Stock Based Compensation: kr161 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RPS Medicover AB LTS:0RPS
90 GF Score
Price kr221.50
GF Value kr234.24
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Medicover AB Stock Based Compensation?

Medicover AB LTS:0RPS -3.06% 90 Stock Based Compensation is kr161 Mil as of Mar. 2026. GuruFocus rates LTS:0RPS with a GF Score™ of 90/100 and a GF Value™ of kr234.24 (Fairly Valued). The stock has 5 warning signs investors should review.

Medicover AB's Stock Based Compensation for the three months ended in Mar. 2026 was kr32 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was kr161 Mil.

Medicover AB Stock Based Compensation Related Terms

Medicover AB Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Medicover AB's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicover AB Stock Based Compensation Chart

Medicover AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.73 105.54 105.15 140.33 167.59

Medicover AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.53 39.65 40.70 47.88 32.31
LTS:0RPS
90GF Score
Medicover AB LTS:0RPS
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicover AB Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr161 Mil.

What does a Stock Based Compensation of kr161 Mil mean?
Medicover AB (LTS:0RPS) has a Stock Based Compensation of kr161 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Medicover AB and its competitors.
Is Medicover AB's Stock Based Compensation too high?
Medicover AB's current Stock Based Compensation is kr161 Mil. Overall, Medicover AB has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Stock Based Compensation compare to HCA and THC?
Medicover AB's Stock Based Compensation of kr161 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Medicover AB and its competitors. Medicover AB's current Stock Based Compensation is kr161 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr234.24, compared to a current price of kr221.50 — trading 5.4% below its estimated fair value. The current Stock Based Compensation is kr161 Mil. Medicover AB's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Stock Based Compensation is kr161 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (LTS:0RPS) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be undervalued. The current stock price of kr221.50 is trading 5.4% below its estimated GF Value™ of kr234.24. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for LTS:0RPS:

  • Stock Based Compensation: kr161 Mil
  • GF Value™: kr234.24 vs. price of kr221.50 (5.4% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
90GF Score

Get the complete analysis for LTS:0RPS

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr221.50
Price
kr234.24
GF Value